Showing results (521-530 of 570) with videos related to

Sort By:
Pageof 57
JAMA|December 12, 2001
Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk AssessmentE S Siris, P D Miller, E Barrett-Connor, et al.
Lancet (London, England)|February 29, 1992
HPV-16-related DNA sequences in Kaposi's sarcomaY Q Huang, J J Li, M G Rush, et al.
Metabolic Engineering|July 31, 2014
Use of pantothenate as a metabolic switch increases the genetic stability of farnesene producing Saccharomyces cerevisiaeCeleste M Sandoval, Marites Ayson, Nathan Moss, et al.
TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik|March 21, 2003
A set of simple-sequence repeat (SSR) markers covering the Prunus genomeM J Aranzana, A Pineda, P Cosson, et al.
FEBS Letters|February 16, 2008
Stromal cell-derived factors 1alpha and 1beta, inflammatory protein-10 and interferon-inducible T cell chemo-attractant are novel substrates of dipeptidyl peptidase 8Katerina Ajami, Melissa R Pitman, Claire H Wilson, et al.
International Journal of Environmental Research and Public Health|February 12, 2021
The Development of a WTC Environmental Health Center Pan-Cancer DatabaseYongzhao Shao, Nedim Durmus, Yian Zhang, et al.
AIDS and Behavior|January 10, 2013
An evaluation of methods to improve the reporting of adherence in a placebo gel trial in Andhra Pradesh, IndiaSharon A Abbott, Barbara A Friedland, Avina Sarna, et al.
Global Journal of Health Science|April 27, 2013
Sexually transmitted infections and reproductive health morbidity in a cohort of female sex workers screened for a microbicide feasibility study in Nellore, IndiaAvina Sarna, Barbara A Friedland, Aylur K Srikrishnan, et al.
Scandinavian Journal of Immunology|January 5, 2011
Soluble CD26 / dipeptidyl peptidase IV enhances human lymphocyte proliferation in vitro independent of dipeptidyl peptidase enzyme activity and adenosine deaminase bindingD M T Yu, L Slaitini, V Gysbers, et al.
Anti-Cancer Drugs|April 6, 2001
Biodistribution of NX211, liposomal lurtotecan, in tumor-bearing miceJ P Desjardins, E A Abbott, D L Emerson, et al.
Pageof 57